Beam Therapeutics Inc (BEAM)
33.04
-0.92
(-2.71%)
USD |
NASDAQ |
Mar 28, 16:00
32.72
-0.32
(-0.97%)
Pre-Market: 20:00
Beam Therapeutics Profit Margin (Quarterly): 45.16% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 45.16% |
September 30, 2023 | -558.9% |
June 30, 2023 | -411.5% |
March 31, 2023 | -398.5% |
December 31, 2022 | -191.4% |
September 30, 2022 | -693.6% |
June 30, 2022 | -432.1% |
March 31, 2022 | -820.8% |
December 31, 2021 | -126.7% |
September 30, 2021 | -3.69K% |
Date | Value |
---|---|
June 30, 2021 | -1.27M% |
March 31, 2021 | -3.36M% |
December 31, 2020 | -1.59M% |
September 30, 2020 | -574.2K% |
June 30, 2020 | -570.3K% |
March 31, 2020 | -507.6K% |
December 31, 2019 | -464.2K% |
September 30, 2019 | -316.8K% |
June 30, 2019 | -297.7K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.36M%
Minimum
Mar 2021
45.16%
Maximum
Dec 2023
-471.5K%
Average
-3.69K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
Intellia Therapeutics Inc | -- |
Moderna Inc | 7.71% |
Cerus Corp | -2.84% |
908 Devices Inc | -51.77% |
Editas Medicine Inc | -31.43% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -16.29% |
Return on Assets | -9.78% |
Return on Invested Capital | -16.29% |
Operating Margin (Quarterly) | 42.02% |
Return on Net Operating Assets | -55.60% |